Gepirone

An overview of the anxiolytic and antidepressant drug Gepirone

Gepirone
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Gepirone is a pharmaceutical compound that belongs to the class of azapirones, which are known for their anxiolytic and antidepressant properties. It is primarily used in the treatment of anxiety disorders and depression.

Pharmacology

Gepirone functions as a selective partial agonist of the 5-HT1A receptor, a subtype of the serotonin receptor. This action is believed to contribute to its anxiolytic and antidepressant effects. Unlike traditional benzodiazepines, gepirone does not exhibit sedative or muscle relaxant properties, making it a preferable option for patients who need to avoid these side effects.

Mechanism of Action

Chemical structure of Gepirone

Gepirone's mechanism of action involves modulation of the serotonergic system. By partially activating the 5-HT1A receptors, gepirone enhances serotonergic neurotransmission, which is associated with mood regulation and anxiety reduction. This mechanism is similar to that of other azapirones, such as buspirone.

Clinical Use

Gepirone is indicated for the treatment of generalized anxiety disorder (GAD) and major depressive disorder (MDD). It is particularly useful in patients who are sensitive to the side effects of other anxiolytics or antidepressants. Gepirone is typically administered orally, and its dosage is adjusted based on the patient's response and tolerance.

Side Effects

Common side effects of gepirone include dizziness, nausea, headache, and insomnia. These side effects are generally mild and tend to diminish with continued use. Unlike benzodiazepines, gepirone does not cause dependency or withdrawal symptoms, making it a safer long-term treatment option.

Development and Approval

Gepirone was developed as part of a class of drugs aimed at providing anxiolytic and antidepressant effects without the drawbacks of traditional medications. Although it has shown promise in clinical trials, its approval status varies by country, and it may not be available in all markets.

Related pages

• Anxiety disorder
• Major depressive disorder
• 5-HT1A receptor
• Azapirones
• Buspirone